Details about Manuel Hermosilla

Access statistics for papers by Manuel Hermosilla.

Last updated 2020-05-19. Update your information in the RePEc Author Service.

Short-id: phe632

Working Papers

2020

1. Expected Profits and The Scientific Novelty of Innovation
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (8)

2017

2. Can Emerging Markets Tilt Global Product Design? Impacts of Chinese Colorism on Hollywood Castings
   MPRA Paper, University Library of Munich, Germany View citations (2)
3. Therapeutic Translation of Genomic Science: Opportunities and limitations of GWAS
   NBER Working Papers, National Bureau of Economic Research, Inc
   See also Chapter Therapeutic Translation of Genomic Science: Opportunities and Limitations of GWAS, NBER Chapters, National Bureau of Economic Research, Inc (2018) View citations (2) (2018)

2014

4. Pharmaceutical Profits and the Social Value of Innovation
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (21)

2009

5. Renegociación de concesiones en Chile
   Documentos de Trabajo, Centro de Economía Aplicada, Universidad de Chile View citations (21)

Journal Articles

2019

1. Structural Models of the Prescription Drug Market
   Foundations and Trends(R) in Marketing, 2019, 13, (1), 1–76 View citations (6)

2018

2. Market size and innovation: The intermediary role of technology licensing
   Research Policy, 2018, 47, (5), 980-991 View citations (12)

Chapters

2018

1. Therapeutic Translation of Genomic Science: Opportunities and Limitations of GWAS
   A chapter in Economic Dimensions of Personalized and Precision Medicine, 2018, pp 21-52 View citations (2)
   See also Working Paper Therapeutic Translation of Genomic Science: Opportunities and limitations of GWAS, National Bureau of Economic Research, Inc (2017) (2017)